中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 10
Oct.  2018
Turn off MathJax
Article Contents

Predictive value of coagulation test parameters for acute upper gastrointestinal bleeding in patients with liver cirrhosis

DOI: 10.3969/j.issn.1001-5256.2018.10.014
Research funding:

 

  • Published Date: 2018-10-20
  • Objective To investigate the association between coagulation test parameters and acute upper gastrointestinal bleeding ( AUGIB) in patients with liver cirrhosis. Methods A total of 233 patients with liver cirrhosis who were hospitalized in Department of Gastroenterology, Jiading District Central Hospital, Shanghai University of Medicine & Health Sciences, from January 2013 to December 2016, and according to the presence or absence of AUGIB, they were divided into AUGIB group with 87 patients and non-AUGIB group with 146 patients. Related clinical data were collected, including name, sex, age, cause of liver cirrhosis, ascites, hepatic encephalopathy, blood parameters of the first blood test after admission [routine blood test results, total bilirubin ( TBil) , albumin, and creatinine], coagulation test results [prothrombin time ( PT) , prothrombin time activity ( PTA) , activated partial thromboplastin time ( APTT) , international normalized ratio ( INR) , fibrinogen ( FIB) , thrombin time ( TT) ], and D-dimer. The Child-Pugh score and Model for End-Stage Liver Disease ( MELD) score were calculated based on these data. The independent samples t-test was used for comparison of continuous data between two groups, and an analysis of variance was used for comparison between multiple groups. Logistic regression was used for univariate and multivariate analyses of related variables. Results Compared with the patients with Child-Pugh class A/B liver cirrhosis, the patients with Child-Pugh class C liver cirrhosis had significantly longer PT, APTT, and TT, a significantly higher INR, significant reductions in PTA and FIB, and significant increases in TBil and MELD score ( F = 62. 706, 33. 858, 17. 781, 63. 025, 46. 907, 7. 514, 23. 020, and20. 519, all P < 0. 05) . Of all 233 patients, only 175 underwent the measurement of D-dimer, and D-dimer was not measured for 58 patients, which caused data loss. According to the Child-Pugh class, the 175 patients who underwent D-dimer measurement were divided into Child-Pugh class A group with 33 patients, Child-Pugh class B group with 93 patients, and Child-Pugh class C group with 49 patients, and there was a significant difference in the level of D-dimer between these three groups ( 1. 63 ± 2. 15 mg/L vs 3. 48 ± 4. 25 mg/L vs 4. 24 ± 4. 79 mg/L, F = 4. 089, P = 0. 018) . Compared with the MELD ≥13 group, the MELD < 13 group had significantly longer PT, INR, and APTT and a significant reduction in PTA ( t = 7. 307, 7. 602, 3. 650, and 5. 546, all P < 0. 05) . Among the 87 patients in the AUGIB group, 76 had esophagogastric variceal bleeding, 9 had peptic ulcer, 1 had bleeding due to portal hypertensive gastropathy, and 1 had bleeding due to gastric carcinoma. Compared with the non-AUGIB group, the AUGIB group had a significantly longer APTT, a significantly higher FIB level, and a significantly higher Child-Pugh class ( t = 7. 178, 14. 644, and 30. 082, all P < 0. 05) . APTT and FIB were significantly associated with AUGIB ( APTT: likelihood ratio [LR]= 1. 09, 95% confidence interval [CI]: 1. 04-1. 14, P < 0. 001; FIB:LR = 2. 34, 95% CI: 1. 61-3. 41, P < 0. 001) . Conclusion The increases in PT, INR, and APTT parallel with Child-Pugh class and MELD score in patients with liver cirrhosis, and the prolongation of APTT and the increase in FIB can predict the possibility of AUGIB in patients with liver cirrhosis.

     

  • loading
  • [1]JAIRATH V, REHAL S, LOGAN R, et al.Acute variceal haemorrhage in the United Kingdom:Patient characteristics, management and outcomes in a nationwide audit[J].Dig Liver Dis, 2014, 46 (5) :419-426.
    [2]SVOBODA P, KONECNY M, MARTINEK A, et al.Acute upper gastrointestinal bleeding in liver cirrhosis patients[J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2012, 156 (3) :266-270.
    [3]KUJOVICH JL.Coagulopathy in liver diseas:A balancing act[J].Hematology Am Soc Hematol Educ Program, 2015, 2015 (1) :243-249.
    [4]LI J, QI X, DENG H, et al.Association of conventional haemostasis and coagulation tests with the risk of acute upper gastrointestinal bleeding in liver cirrhosis:A retrospective study[J].Gastroenterol Rep (Oxf) , 2016, 4 (4) :315-319.
    [5]KAMATH PS, WIESNER RH, MALINCHOC M, et al.A model to predict survival in patients with end-stage liver disease[J].Hepatology, 2001, 33 (2) :464-470.
    [6]CHAWLA YK, KASHINATH RC, DUSEJA A, et al.Predicting mortality across a broad spectrum of liver disease:An assessment of model for end-stage liver disease (meld) , child-turcotte-pugh (CTP) , and creatinine-modified ctp scores[J].J Clin Exp Hepatol, 2011, 1 (1) :161-168.
    [7]TRIPODI A.The coagulopathy of chronic liver disease:Is there a causal relationship with bleeding?NO[J].Eur J Intern Med, 2010, 21 (2) :65-69.
    [8]BASILI S, RAPARELLI V, VIOLI F.The coagulopathy of chronic liver disease:Is there a causal relationship with bleeding?Yes[J].Eur J Intern Med, 2010, 21 (2) :62-64.
    [9]JAMIL Z, MALIK M, DURRANI AA.Platelet count to splenic diameter ratio and other noninvasive markers as predictors of esophageal varices in patients with liver cirrhosis[J].Turk J Gastroenterol, 2017, 28 (5) :347-352.
    [10]PENG Y, QI X, DAI J, et al.Child-Pugh versus MELD score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis[J].Int J Clin Exp Med, 2015, 8 (1) :751-757.
    [11]ZOCCO MA, di STASIO E, de CRISTOFARO R, et al.Thrombotic risk factors in patients with liver cirrhosis:Correlation with MELD scoring system and portal vein thrombosis development[J].J Hepatol, 2009, 51 (4) :682-689.
    [12]LISMAN T, PORTE RJ.Rebalanced hemostasis in patients with liver disease:evidence and clinical consequences[J].Blood, 2010, 116 (6) :878-885.
    [13]TRIPODI A, MANNUCCI PM.The coagulopathy of chronic liver disease[J].N Engl J Med, 2011, 365 (2) :147-156.
    [14]LEE JH, KWEON OJ, LEE MK, et al.Clinical usefulness of international normalized ratio calibration of prothrombin time in patients with chronic liver disease[J].Int J Hematol, 2015, 102 (2) :163-169.
    [15]TRIPODI A, PRIMIGNANI M, LEMMA L, et al.Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method[J].Hepatology, 2010, 52 (1) :249-255.
    [16]FENG L, SUN K, ZHANG J, et al.A novel non-invasive index using AFP and APTT is associated with liver fibrosis in patients with chronic hepatitis B infection:A retrospective cohort study[J].BMJOpen, 2015, 5 (9) :e008032.
    [17]TRIPODI A, PRIMIGNANI M, CHANTARANGKUL V, et al.An imbalance of pro-vs anti-coagulation factors in plasma from patients with cirrhosis[J].Gastroenterology, 2009, 137 (6) :2105-2111.
    [18]TROTTER JF, BRIMHALL B, ARJAL R, et al.Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation[J].Liver Transpl, 2004, 10 (8) :995-1000.
    [19]TRIPODI A, SALERNO F, CHANTARANGKUL V, et al.Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests[J].Hepatology, 2005, 41 (3) :553-558.
    [20]LIAO WC, HOU MC, CHANG CJ, et al.Potential precipitating factors of esophageal variceal bleeding:A case-control study[J].Am J Gastroenterol, 2011, 106 (1) :96-103.
    [21]GIANNINI EG, GRECO A, MARENCO S, et al.Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease[J].Clin Gastroenterol Hepatol, 2010, 8 (10) :899-902.
    [22]HONG WD, DONG LM, JIANG ZC, et al.Prediction of large esophageal varices in cirrhotic patients using classification and regression tree analysis[J].Clinics (Sao Paulo) , 2011, 66 (1) :119-124.
    [23]MADHOTRA R, MULCAHY HE, WILLNER I, et al.Prediction of esophageal varices in patients with cirrhosis[J].J Clin Gastroenterol, 2002, 34 (1) :81-85.
    [24]ZAMAN A, BECKER T, LAPIDUS J, et al.Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage[J].Arch Intern Med, 2001, 161 (21) :2564-2570.
    [25]LALOSEVIC MS, STOJKOVIC M, NAUMOVIC T, et al.Clinical scores for the prediction of esophageal varices in patients with liver cirrhosis[J].Acta Gastroenterol Belg, 2016, 79 (1) :14-17.
    [26]SHARARA AI, ROCKEY DC.Gastroesophageal variceal hemorrhage[J].N Engl J Med, 2001, 345 (9) :669-681.
    [27]QI X, CHEN H, HAN G.Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis:A meta-analysis[J].Am J Med Sci, 2013, 346 (1) :38-44.
    [28]TISCHENDORF M, MIESBACH W, CHATTAH U, et al.Differential kinetics of coagulation factors and natural anticoagulants in patients with liver cirrhosis:Potential clinical implications[J].PLo S One, 2016, 11 (5) :1-9.
    [29]TRIPODI A, CALDWELL SH, HOFFMAN M, et al.Review article:The prothrombin time test as a measure of bleeding risk and prognosis in liver disease[J].Aliment Pharmacol Ther, 2007, 26 (2) :141-148.
    [30]SEGAL J, DZIK W.Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures:An evidence-based review[J].Transfusion, 2005, 45 (9) :1413-1425.
    [31]TACKE F, FIEDLER K, von DEPKA M, et al.Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease[J].Liver Int, 2006, 26 (2) :173-181.
    [32]GARBUZENKO DV.Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding[J].Curr Med Res Opin, 2016, 32 (3) :467-475.
    [33]BENDTSEN F, D'AMICO G, RUSCH E, et al.Effect of recombinant factor VIIa on outcome of acute variceal bleeding:an individual patient based meta-analysis of two controlled trials[J].J Hepatol, 2014, 61 (2) :252-259.
    [34]BOSCH J, THABUT D, ALBILLOS A, et al.Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis:A randomized, controlled trial[J].Hepatology, 2008, 47 (5) :1604-1614.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2032) PDF downloads(365) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return